However, ICAM-1 upregulation exceeded MHC-class I upregulation (ratio <1) in the EWS cell lines CHLA-9 and CHLA-10 and the lymphoma cell line Ramos-RA1, for which IFNγ treatment resulted in decreased NK cell-mediated lysis. The gene discussed is ICAM1; the disease is lymphoma.